COVID-19 vaccine soon? Why you need to keep the mask on for now

COVID Vaccine
Bharat Biotech’s Covaxin, an inactivated virus vaccine for novel coronavirus, is a sweet respite coming amid the rise in COVID-19 cases in India | Image - Prathap Ravishankar

With COVID-19 cases touching 6 lakhs and counting, the unanticipated but pleasant announcement by the Bharat Biotech of COVAXIN, an inactivated virus vaccine for novel coronavirus, came as a sweet respite. In the widely reported letter, the Director-General of the Indian Council for Medical Research (ICMR), has directed everyone to speed up the clinical trials.

How does a vaccine work? What is inactivated virus? How is it developed? At what stage are we in the development process? Realistically, how long will it take for the vaccine to be developed and deployed for public use.

In simple terms, an effective vaccine is a trigger that trains our 'immune system' to recognise the pathogen, say novel coronavirus, and produce appropriate antibodies and T-cells that can neutralise the virus when the infection actually occurs.

Antigen and antibodies

To continue reading this article...

You have to be a Premium Subscriber

Start your subscription with a free trial

Enjoy unlimited Eighth column, archives and games on
The Federal.com and The Federal APP and many more features.
You will also be supporting ethical and unbiased journalism.
After trial subscription plans start from Rs. 99
Get breaking news and latest updates from India
and around the world on thefederal.com
FOLLOW US: